| Name | Title | Contact Details |
|---|---|---|
Angela Drysdale |
VP, Regulatory Affairs - Infectious Disease | Profile |
Ellen Chiniara |
General Counsel | Profile |
Crunch is a No Judgment Gym that believes in making serious exercise fun by fusing fitness and entertainment. Join Crunch for all your fitness needs!
Wells Fargo Insurance is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At Curo, we are committed to clinical excellence and integrity, insuring our patients the highest quality of care and comfort. To maintain this commitment we hire only the most experienced and capable hospice and home health care professionals. Our clinical team members are experts in pain and symptom management, and our support team members are skilled in the specific issues of emotional support, spiritual counseling, and resource referral.
Since 1970, Spokane Mental Health, a not-for-profit organization, has served children, families, adults and elders throughout Spokane County.
Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.